Faisal Mahmood
Scholar

Faisal Mahmood

Google Scholar ID: 9MsdbKoAAAAJ
Associate Professor, Harvard University
Citations & Impact
All-time
Citations
13,197
 
H-index
45
 
i10-index
70
 
Publications
20
 
Co-authors
0
 
Resume (English only)
Academic Achievements
  • Developed pathology foundation models UNI (published in Nature Medicine) and CONCH (published in Nature Medicine).
  • Created PathChat, a generative AI chatbot/multimodal large language model for human pathology (published in Nature).
  • PathChat DX, the clinical-grade version of PathChat, received FDA Breakthrough Device Designation—among the first generative AI tools in pathology to do so.
  • Introduced KRONOS, a foundation model for spatial proteomics.
  • Proposed VORTEX, an AI-driven 3D spatial transcriptomics method.
  • Released open-source libraries TRIDENT (for large-scale WSI batch processing) and Patho-Bench (for foundation model benchmarking).
  • Proposed THREADS, a molecular-driven foundation model for pathology.
  • Published a paper on transferability of MIL models at ICML 2025.
  • Published a commentary on benchmarking in machine learning for biomedicine in Nature Medicine.
  • PhD student Cristina Almagro-Pérez awarded the prestigious Rafael del Pino Foundation Fellowship.
Background
  • Develops machine learning, data fusion, and medical image analysis methods for objective diagnosis, prognosis, and biomarker discovery.
  • Focuses on using AI as an assistive tool for pathologists to reduce interobserver and intraobserver variability in cancer diagnosis.
  • Develops novel algorithms to identify clinically relevant morphologic phenotypes and biomarkers associated with response to specific therapeutics.
  • Builds multimodal fusion algorithms integrating imaging modalities, patient/family histories, and multi-omics data for precise diagnostic, prognostic, and therapeutic decisions.
  • Affiliated with the Harvard Data Science Initiative, Harvard Bioinformatics and Integrative Genomics (BIG) program, Dana-Farber Cancer Institute’s Cancer Data Science Program, and the Cancer Program at the Broad Institute of Harvard and MIT.
Co-authors
0 total
Co-authors: 0 (list not available)